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Abstract
The functional and biological significance of selected CASP13 targets are described
by the authors of the structures. The structural biologists discuss the most interesting
structural features of the target proteins and assess whether these features were cor-
rectly reproduced in the predictions submitted to the CASP13 experiment.
K E YWORD S
CASP, protein structure prediction, cryo-EM, X-ray crystallography
1 | INTRODUCTION
Community wide experiment on the Critical Assessment of Techniques
for Protein Structure Prediction (CASP) operation would not be possible
without the help of experimental structural biologists, who agree to
share with the CASP organization their work-in-progress or recently
solved protein structures in advance of their public release. In the latest
round of CASP (CASP13, 2018), 75 proteins and protein complexes
were suggested as modeling targets by 36 structure determination
groups from 14 countries. All suggested entries were released for pre-
diction, however, eight of them were canceled due to lack of structure
by the time of the assessment or release of relevant structural informa-
tion before the end of the target prediction season. Of the remaining
67 entries, 58 were solved by X-ray crystallography, 7 with cryo-EM
and 2 by NMR. When classified by quaternary structure, 25 entries
were monomeric, 30 homo-oligomeric and 12 heteromeric. The hetero-
meric complexes were released for prediction (and later assessed) as
both, whole multimolecular complexes (12) and constitutive subunits
(25). All in all, 80 single-molecule targets and 42 multi-molecule targets
were part of the CASP13 experiment. CASP organizers, who are co-
authors of this article, want to thank every experimentalist who contrib-
uted to CASP13 (see Table S1) and this way helped developing more
effective protein structure prediction methods.
The chapters of the article reflect the views of the contributing
authors on 13 CASP13 targets (Table 1), including three monomeric:
the Arabidopsis thaliana xylan O-acetyltransferase 1 (T0969), the
LP1413 single-strand DNA binding protein (T0958), the WD40-repeat
domain of the human E3 ubiquitin ligase RFWD3 (T0954); 4 homo-
oligomeric: the H1 domain of human KCTD8 (T0970), a putative
ACAD from B. bacteriovorus (T0961), a glycoside hydrolase family
31 α-xylosidase (T1009), the pentafunctional AROM Complex from
Chaetomium thermophilum (T0999); 6 hetero-oligomeric: the receptor-
binding tip (gp373-gp38) from the Salmonella phage S16 (H0953), the
toxin-immunity protein complex from Escherichia coli 3006 (H0957),
and Klebsiella pneumoniae 342 (H0968), the human MAJIN-TERB2
hetero-tetrameric complex (H0980), the apical end cap of the anti-
feeding prophage (AFP) from Serratia entomophila and its threefold
symmetric needle (H1021 and H1022).
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The results of the comprehensive numerical evaluation of CASP13
models are available at the Prediction Center website (http://www.
predictioncenter.org). The detailed assessment of the models by the
assessors is provided elsewhere in this issue.
2 | RESULTS
2.1 | Structure of the WD40-repeat domain of the
human E3 ubiquitin ligase RFWD3 (CASP: T0954;
PDB: 6CVZ). Provided by Cody Caba, Peter Loppnau,
and Yufeng Tong
Ubiquitination is the covalent attachment of ubiquitin (Ub) to a sub-
strate lysine. It represents the second most prevalent post-
translational modification and follows a three-step enzymatic cascade
involving an E1 Ub-activating enzyme, E2 Ub-conjugating enzyme,
and an E3 Ub-protein ligase. The diverse distribution of E3s, for which
>600 are known to exist in the human genome, affords the
ubiquitome pervasive substrate specificity. As such, Ub-modified tar-
gets are ultimately destined for a myriad of molecular outcomes
depending on the Ub chain length and linkage type.1 Many proteins of
the E3 superfamily incorporate the highly abundant WD40-repeat
(WDR) substrate-recruiting domain as a functional protein-nucleic acid
and protein-protein interaction (PPI) module. As a vital component to
many multiprotein complexes, the WDR domain is unsurprisingly cen-
tral to a range of cellular processes, including checkpoint signaling,
protein trafficking and degradation, DNA replication, and DNA dam-
age repair (DDR). RFWD3 (RING finger and WD repeat domain-
containing protein 3) is a WDR-containing E3 originally identified as
an ATM/ATR substrate involved in DDR.2,3 Evidence has shown that
the WDR domain is primarily responsible for the functional interac-
tions that allow RFWD3 to maintain genomic stability.4,5 Furthermore,
heritable mutations, particularly an Ile639Lys point mutation within
the WDR domain, may lead to the rare genomic instability disease
known as Fanconi anemia (FA),6 thereby implicating RFWD3 as a
potential FA-associated gene (alias: FANCW).4-6 Until recently, the bio-
chemical characterization of RFWD3 has lacked complementary high-
resolution structural information. Here, we discuss the 1.8 Å resolu-
tion X-ray crystal structure of the C-terminal WDR domain of human
RFWD3 (Table 1, Target: T0954; PDB: 6CVZ).
WDR domains exhibit a β-propeller architecture typically com-
posed of seven WD repeats (propeller blades). Each repeat is a four-
stranded antiparallel β-sheet of 40 to 60 residues in length. Other fea-
tures, though not conserved, may exist within the repeats, such as a
DH(S/T)W hydrogen-bonded tetrad, or GH and WD dipeptides. Due
to low sequence homology, predicting the presence of WDR domains
with sequence analysis alone is difficult and results in an underrepre-
sentation within the proteome.7 Some of the common protein
sequence analysis databases predict RFWD3 to contain three distinct
WDRs, while the more specialized WDSP database7 suggests the
presence of six8; however, our structure reveals seven. Stabilizing the
fold are hydrophobic interactions between adjacent repeats, along
TABLE 1 CASP13 target highlights
CASP13 assessment
Target PDB Method Resolution (Å) Stoichiometry Size Protomer Assembly
GDT-TS IDDT QS-score
T0969 6CCI X-ray 1.85 A1 487 58.19 0.51 -
T0958 6BTC X-ray 2.18 A1 96 80.84 0.69 -
T0954 6CVZ X-ray 1.80 A1 350 72.02 0.66 -
T0970 6G57 X-ray 2.80 A2 97 67.94 0.28 0.64
T0961 6SD8 X-ray 1.50 A4 505 91.65 0.80 0.91
T1009 6DRU X-ray 2.70 A2 718 71.24 0.64 0.18
T0999 N/A X-ray 3.00 A2 1589 80.39 0.73 0.82
H0953 6F45 X-ray 1.70 A3B1 72
249
54.48
40.12
0.63
0.40
0.37
H0957 6CP8 X-ray 2.20 A1B1 163
164
45.22
60.97
0.57
0.57
0.07
H0968 6CP9 X-ray 2.55 A2B2 126
116
71.40
78.70
0.61
0.66
0.14
H0980 6GNX X-ray 2.90 A2B2 111
52
54.81
-
0.45
-
0.08
H1021 6RAP EM 3.30 A6B6C6 149
354
295
75.67
68.70
36.77
0.65
0.58
0.57
0.33
H1022 6RBK EM 3.40 A6B3 229
529
43.61
62.25
0.55
0.59
0.43
Note: Columns indicate target ID, PDB ID, experimental method, resolution, stoichiometry, size, and CASP13 assessment results. For each target, the accuracy
of the best model 1 is provided both at the level of individual protomers (best GDT-TS and corresponding IDDT score) and full assembly (best QS-score).
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with a velcro closure between the first and last repeats. Additionally,
there is an exposed disulfide bond on the top surface linking repeats
five and six (Cys638 to Cys696, Figure 1A). It is yet to be determined
whether this is important for conformational stability or a potential
site of redox-regulated activity. Multiple sequence alignment suggests
these cysteine residues are not well conserved. Additionally, only a
single WD dipeptide is present (WD730), located at the C-terminus of
the third strand in repeat six. It should also be noted that a coordi-
nated magnesium ion in the structural model is an artifact of the crys-
tallization condition with no biological relevance (Figure 1A).
Molecular recognition by WDR domains occurs via the top, bot-
tom, sides, and central cavity. Specific PPIs are believed to be
governed by the sequence insertions outside of the repeats them-
selves, such as the extended loops that decorate the top and bottom
faces. A Dali search was used to determine if such insertions exist in
the WDR domain of RFWD3 in comparison to closely related struc-
tural homologs. Included in the top hits were WDR5 (WD repeat-
containing protein 5; PDB: 6DAS, LGA score: 69.6) and RFWD2
(PDB: 5HQG, LGA score: 61.3). Alignment of the structures revealed
that RFWD3 does indeed contain distinct insertions in the form of
disordered loops on the top and bottom faces, specifically
encompassing residues 467 to 477, 594 to 606, and 656 to 664 (Fig-
ure 1B, panels i-iii, respectively). Furthermore, elongated strands of
repeat five appear to be a feature unique to RFWD3 (Figure 1B panel
iv). Interestingly, residues involved in DDR are not part of these inser-
tions, including Trp-543 and Ile-639 for binding RPA32, and the
QKMDF624 consensus motif that mediates the interaction with PCNA
(proliferating cell nuclear antigen) during DNA replication.5
Many disease-associated mutations exist within the WDR domain,
presenting RFWD3 as a potential anti-cancer target. The COSMIC (cat-
alogue of somatic mutations in cancer) database was used to identify
solvent-exposed point mutations that may have roles in various cancers
(Figure 1C). For example, mutation Cys638Tyr, identified in a whole-
genome screen of colorectal cancers, would abolish the observed
Cys638 to Cys696 disulfide (Figure 1A), whereas the FA-related
Ile639Lys mutation will disrupt the hydrophobic packing around Ile639
and likely lead to a destabilized protein. Another interesting feature of
this domain is the surface charge distribution about the top and bottom
faces (Figure 1D). A large electropositive surface is present on the top
face in contrast to a large electronegative surface on the bottom. During
DDR, RFWD3 stabilizes p53 by binding Mdm2 (an E3 and negative reg-
ulator of p53). We propose that the acidic domain of Mdm23 binds the
positively charged top surface of the WDR domain. Indeed, this surface
characteristic would also suggest the potential for phosphopeptide rec-
ognition, similar to that observed with RFWD2.9
How was CASP13 able to predict and model the structure of this
important target? Overall, the modeling efforts were successful with
56 predictions (out of 86 total) providing GDT-TS scores >50. Group
A7D was the most accurate structural predictor with a GDT-TS score
of 72.0 and an RMSD of 1.87 Å across 2066 atom pairs. Superposition
with the crystal structure reveals the overall topology (Figure 1A),
including the large disordered loops (Figure 1B), was well reproduced
F IGURE 1 The WDR domain of human RFWD3. A, Schematic representation of RFWD3's domain organization and cartoon representation
of the WDR domain crystal structure (6CVZ; cyan) aligned with the most accurately predicted model T0954TS043_1 (light blue). All seven blades
of the β-propeller architecture are labeled. The magnesium ion (green sphere) is octahedrally coordinated by the oxygen of six water molecules
(oxygen atoms shown as red spheres). The 2mFo-DFc electron density map is shown contoured to 2.0 σ. The volume of the central cavity is
provided as a surface representation (determined using POCASA v. 1.1). RING, really interesting new gene; CC, coiled-coil. B, Alignment of 6CVZ
(rainbow), 6DAS (dark gray), 5HQG (light gray), and model T0954TS043_1 (light blue). Loops of interest are circled and labeled i to iv,
respectively. C, Visualization of the key residues involved in DDR (blue) and the solvent-exposed residues identified to be mutated in various
cancers using the COSMIC database (red). The disease-related point mutations (red) are tabulated. D, Electrostatic potential map of 6CVZ from
−3 kT/e (red) to +3 kT/e (blue). All structural figures were prepared using PyMOL (v. 2.3.0, Schrödinger LLC)
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in the model. Importantly, this was achieved despite the notoriously
low sequence similarity between homologous WDR domain-
containing proteins.
2.2 | The H1 domain of human KCTD8 (CASP:
T0970, PDB: 6G57). Provided by Daniel M. Pinkas,
Joshua C. Bufton, and Alex N. Bullock
KCTD1-21 form a subgroup of BTB domain-containing proteins that
commonly function as Cullin3-dependent E3 ligases.10 For example,
KCTD5 is observed to act as a Cullin3 dependent off-switch for GPCR
signaling through ubiquitin-mediated degradation of Gβγ under certain
conditions.11 Similarly, KCTD6, KCTD11, and KCTD21 have been
observed to ubiquitylate HDAC1 in complex with Cullin3, thereby
suppressing Hedgehog activity in Medulloblastoma.12 KCTD8, KCTD12,
and KCTD16 lack Cullin3 binding and instead act as auxiliary subunits
of the GABAB2 receptors
13 that help to modulate signaling outcomes.14
KCTD8 consists of an N-terminal region of 41 amino acids that is
predicted to be unstructured, followed by a BTB domain, which medi-
ates interaction with the GABAB2 receptor
15and also axially homo-
and hetero-associates with the BTB domains of KCTD12 and
KCTD16.16 This region is followed by a low complexity region of
54 amino acids and a poorly characterized domain that is conserved
between KCTD8, KCTD12, and KCTD16, termed the “H1” domain. C-
terminal to this domain is another region that is homologous between
KCTD8 and KCTD16 but missing in KCTD12, dubbed “H2.” The H2
region is predicted to be largely unstructured,17 but contains a signifi-
cant HHpred18 signature for a small alpha helical domain with
predicted structural homology to a Yeast Mediator of RNA polymer-
ase II (4H62_V) at the C-terminus of the H2 region.
The KCTD8 H1 domain was solved at the SGC and refined to a
resolution of 2.75 Å (Table 1, Target: T0970; PDB: 6G57, UniProt:
Q6ZWB6, construct residues 201-322). Despite sharing very low
sequence identity with any solved crystal structures, a top HHpred hit
is detected with a probability score of 77.8% to rat GTP
Cyclohydrolase I Feedback Regulatory Protein (GFRP, PDB: 1JG5_B,
Figure 2A). The HHpred match only covers 22% of the protein
sequence (27/122 residues) and does not correspond to a contigu-
ously interacting folded segment (Figure 2A). Despite the low conser-
vation, the HHpred hit shows a good overall fit to the KCTD8 H1
domain with an LGA score of 58.7 (Figure 2B).19
The top scoring model (T0970TS112_1-D1, GDT-TS = 67.94) has
a similar LGA score of 56.1 (Figure 2C), and faithfully recapitulates
some important aspects of the true overall fold, although missing
some key features such as an extended C-terminal β-hairpin (star) and
a short β-strand pair (triangle) that is conserved between GFRP and
KCTD8. However, the extended C-terminal beta hairpin was correctly
predicted in the sixth best overall scoring model (T0970TS043_1-D1,
GDT-TS = 63.23), and the short beta strand pair correctly predicted in
the second best scoring model (T0970TS149_1-D1, GDT-TS = 66.18).
Overall, several interesting points arise from analysis of the
predicted structures. First, the fact that the GFRP template itself has a
slightly higher LGA score than the best solutions raises the question of
whether the excellent fit of this template could have been predicted
and hence incorporated to generate improved constraints on solutions.
Second, although standard high-throughput multi-construct design tech-
niques were used to generate the construct that produced the crystal
structure of KCTD8, the essentially correct prediction of the H1 domain
in this case suggests that current structure prediction techniques could
potentially assist in the process of designing expression constructs.
2.3 | Structure of the human MAJIN-TERB2
heterotetrameric complex (CASP: H0980, PDB:
6GNX). Provided by Manickam Gurusaran and Owen
R. Davies
Meiosis is a two-stage specialized cell cycle that produces haploid
germ cells by reducing the chromosome number by half. It is thus
F IGURE 2 A, Crystal structure of the top HHpred hit (Rat GFRP, PDB: 1JG5_B) for the H1 domain of human KCTD8. Rat GFRP is shown in
green. The region matching the H1 domain of KCTD8 is highlighted in red. B, Superposition of Rat GFRP crystal structure (depicted as in
Figure 2A) and the crystal structure of human KCTD8 H1 domain (PDB: 6G57, cyan). C, Structure superposition of the crystal structure of human
KCTD8 H1 domain (depicted as in Figure 2B) and the top scoring model from CASP13 (T0970TS112_1-D1, magenta). Two key differences
between model and reference are highlighted: a star highlights the region of the C-terminal beta hairpin structure and a triangle highlights the
short beta strand pair
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essential for reproduction, genetic diversity, and evolution, with errors
in meiosis leading to human infertility, miscarriage and germ cell can-
cers.20 At the center of this process is the establishment of homolo-
gous chromosomes pairs through their physical tethering by the
synaptonemal complex, and the resultant formation of genetic cross-
overs.21,22 To achieve this requires an ornate choreography in which
meiotic chromosomes are rapidly moved around the nucleus to enable
the identification of establishment of homologous pairs through mei-
otic recombination.23 These meiotic prophase movements are driven
by microtubule forces that are transmitted across the nuclear enve-
lope via the LINC complex, and directed to the telomeric ends of mei-
otic chromosomes.24 In mammals, the meiotic telomere complex
(formed by MAJIN, TERB1, and TERB2) physically tethers meiotic
chromosome telomere ends both to the inner nuclear membrane and
the LINC complex,25 thereby permitting microtubule-driven chromo-
some end movements within the plane of the nuclear envelope. The
molecular architecture of the meiotic telomere complex is defined by
a core MAJIN-TERB2 complex that connects its key functionalities.
MAJIN mediates inner nuclear membrane attachment through a trans-
membrane helix, while TERB2 binds to TERB1, which interacts with
shelterin component TRF1 to recruit telomeric DNA, and is also
thought to bind to the LINC complex.25-27 Previous genetic studies in
mice demonstrated that individual disruption of MAJIN, TERB1, or
TERB2 leads to impaired telomere attachment, failure of chromosome
movements and infertility.25-28 We thus initiated structural studies to
understand the molecular basis of this essential process of mammalian
meiosis.
The crystal structure of the MAJIN-TERB2 core complex (Table 1,
Target: H0980; PDB ID: 6GNX) revealed a 2:2 heterotetramer in
which two TERB2 chains wrap around a globular MAJIN dimer
(Figure 3A).29 Each MAJIN protomer adopts a β-grasp fold, in which a
β-sheet grasps around a core α-helix (Figure 3A). The structural archi-
tecture of the β-grasp fold consists of a five-stranded β(2)-
α-β(3) assemblage with a two-stranded β-sheet insertion, which is
seemingly unique to MAJIN-TERB2. The MAJIN dimerization inter-
face is stabilized through aromatic and proline interactions (Figure 3E,
left), with additional stabilization from TERB2. The structure displays
an extensive basic patch on the surface of each MAJIN protein
(Figure 3B), which binds to DNA and thereby provides a novel means
for meiotic telomere recruitment. Further, the relative orientation of
N- and C-termini of both protein components allowed us to model
the architecture of the wider MAJIN-TERB2-TERB1 complex.29
The category of prediction experiments of a MAJIN monomer
included 92 models, of which many successfully predicted a β-grasp
fold (eg, T0980s1TS089_1-D1, GDT-TS = 54.81), while others were
highly divergent (eg, T0980s1TS458_1-D1, GDT-TS = 19.71). Model
T0980s1TS089_1-D1 most closely resembles the MAJIN protomer
of the crystal structure, with a TM-score of 0.54 (GDT-TS = 54.81), and
so is discussed presently. Superposition of model T0980s1TS089_1-D1
onto the MAJIN protomer structure (PDB code: 6GNX, chain A) dem-
onstrates that the topology of the fold was predicted with an impres-
sive level of accuracy (Figure 3C). The core α-helix was predicted with
local Cα RMSD of ~1 Å and interacts with the grasping β-sheet through
largely native contacts; the β-strands are similarly predicted correctly,
although the angulation between α-helix and β-sheet deviates slightly
from then native structure (Figure 3C). The main divergent regions of
the model are the MAJIN N-termini and two-stranded β-sheet inser-
tion. MAJIN N-termini lack secondary structure and form surface
hydrophobic contacts with the remainder of the structure (Figure 3C).
While the β-sheet insertion correctly links between strands of the
grasping β-sheet, its conformation and orientation differ from the crys-
tal structure, although it is possible that the conformation of this region
is stabilized by crystal lattice (Figure 3C). Importantly, the model shows
similar electrostatic properties along the MAJIN DNA binding surface
(Figure 3D).
In the category of oligomeric modeling, there were 73 predictions,
of which none correctly modeled the MAJIN-TERB2 2:2 complex. A
number of models accurately predicted the core of the MAJIN β-grasp
fold but failed to predict the MAJIN dimer interface, which involves
amino acids Pro64, Phe73, Tyr75 (Figure 3E, left). In some cases, the
overall MAJIN dimers show superficial similarity with the crystal
structure, but with incorrect β-grasp topologies placing residues
Pro64, Phe73, Tyr75 far from the interface (eg, TS068_5; Figure 3E,
right). In other cases, the interface shows no resemblance to the crys-
tal structure (eg, TS135_1; Figure 3E, mid). Modeling of TERB2 was
consistently aberrant as it was typically predicted to adopt a small
globular fold that binds to MAJIN, in stark contrast to its extended
conformation wrapping around a MAJIN protomer, through a series of
surface hydrophobic and β-sheet interactions in the crystal structures.
Components of a constitutive complex, such as MAJIN-TERB2, likely
undergo a coordinated folding process in vivo that results in their co-
dependence for stability. This likely highlights an important challenge
in modeling, that in such cases it is inappropriate to predict oligomers
through modeling of prefolded protomers, and instead requires co-
folding of multiple chains in silico.
2.4 | Crystal structure of LP1413, an unusual single-
stranded DNA binding protein (CASP: T0958, PDB:
6BTC). Provided by Ignacio Mir-Sanchis and Phoebe
A. Rice
We named this protein LP1413 as it is a little protein (96 amino acids)
annotated as containing DUF (domain of unknown function) 1413.30
We were interested in its structure and function as part of our ongo-
ing project to understand the SCC family of mobile genomic islands,
many of which carry methicillin resistance. Insertion of these elements
into the Staphylococcus aureus chromosome creates MRSA (methicil-
lin-resistant S. aureus) strains. We have defined the set of core con-
served genes carried by these highly mosaic mobile elements, and are
working to determine their functions.31
LP1413 is encoded in the same operon as a helicase, Cch, that has
sequence homology to replication initiator proteins from a different
family of mobile elements, the SaPIs, and that has structural homology
to MCM helicases.31 We detected no enzymatic activities in purified
LP1413 but found that it binds single-stranded DNA with high affin-
ity. The protein was monomeric in solution30 (Table 1, Target: T0958).
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We thought that LP1413 might be an interesting CASP target
because our crystal structure shows it to be a winged helix-turn-helix
domain (Figure 4A), but it was not annotated as such in sequence
databases. Also, the structure has two unusual features: a β-bulge in
strand 2, and an unusually long turn between helix 3 and strand
2 hosting conserved prolines which helps create a small hydrophobic
pocket (Figure 4B). In the crystal, M1 of an adjacent monomer is
inserted into this pocket. However, we found that an M1G change
caused almost no change in affinity or cooperativity in binding single-
stranded DNA, so the natural ligand for this pocket remains unknown.
Among the highest ranked models according to GDT-TS, all
predicted the correct overall fold except one (T0958TS124_1-D1,
ranked third with GDT-TS = 74.03) where the order of beta strands
2 and 3 was reversed. Overall, the models diverged most in the place-
ment of the shortest helix, helix 2, and the turn between helices 2 and
3. Except for the poorly ordered N- and C-termini, which were not
included in the prediction contest, the backbone atoms of that turn
had the highest backbone B-factors in the model, and was the one
region where the two copies in the asymmetric unit diverged slightly.
This suggests, not surprisingly, that flexibility correlates qualitatively
with difficulty in prediction.
Only 6 of the top 40 models correctly predicted the β-bulge at
Val68. In terms of overall GDT-TS scores, they were near both the
top and the bottom: rank 1, 2, 5, 28, 30, and 39. The top two scoring
models also contained the best predictions for the conformation of
the helix 3––strand 2 turn. These two models, both from the Laufer
F IGURE 3 A, Cartoon
representation of the crystal structure
of MAJIN-TERB2 illustrating a 2:2
hetrotetrameric complex. B, Surface
electrostatic potential (blue:
electropositive; red: electronegative)
of the MAJIN-TERB2 displaying an
extensive basic surface, which
mediates direct interaction with
DNA. C, Superposition and residue-
wise RMSD plot of the MAJIN
protomer (PDB code: 6GNX, chain A)
and T0980s1TS089_1-D1. D, Surface
electrostatic potential (blue:
electropositive; red: electronegative)
of T0980s1TS089_1-D1, MAJIN
protomer (PDB code: 6GNX, chain A)
illustrating the basic patches. Right-
hand panel compares the basic patch
on T0980s1TS089_1-D1 and the
target. E, Compares the MAJIN dimer
interface with the two best models.
Aromatic and proline residues that are
essential for dimer stabilization are
highlighted
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group, also at least partially predicted the hydrophobic pocket,
although this feature was hard to score objectively. Overall, 39 of the
top 40 models predicted the correct fold, and the top two were
remarkably correct in detail. Ironically, had we known that this protein
adopts a winged helix-turn-helix fold, we would have guessed double-
rather than single-stranded DNA binding as its function.
2.5 | Contact-dependent growth inhibition toxin-
immunity protein complexes from E. coli 3006 (CASP:
H0957, PDB: 6CP8) and K. pneumoniae 342 (H0968,
PDB: 6CP9). Provided by Karolina Michalska,
Christopher S. Hayes, Celia W. Goulding, Andrzej
Joachimiak
Bacteria use several mechanisms to communicate, cooperate, and
compete with neighboring microbes in the environment. In dense
communities, bacteria use a number of secretion systems to deliver
protein toxins directly into their competitors.32 This phenomenon was
first discovered in E. coli isolate EC93 and was termed “contact-
dependent growth inhibition” or CDI.33 CDI is mediated by the CdiB
and CdiA two-partner secretion proteins, which form a complex on
the cell surface.33 CdiA is a filamentous protein that extends several
hundred angstroms to interact with receptors on the surface of sus-
ceptible target bacteria. Upon binding its receptor, CdiA undergoes a
series of conformational changes that ultimately deliver its C-terminal
toxin domain (CdiA-CT) into the target cell.34 To protect themselves
from self-intoxication, CDI+ cells also produce a CdiI immunity protein
that binds the CdiA-CT to neutralize toxin activity. Though character-
ized most extensively in E. coli, CDI systems are broadly distributed
throughout Gram-negative bacteria including pathogens35 and have
been implicated in cooperative behaviors, such as biofilm formation,
persistence, and virulence.36-38 CdiA effectors carry extraordinarily
diverse CdiA-CT regions, indicating that the systems deploy many dis-
tinct toxins. Similarly, CdiI sequences are also highly variable, and each
immunity protein only provides protection against its cognate toxin.
Thus, CDI toxin-immunity protein polymorphism underlies an impor-
tant mechanism of self/nonself discrimination in bacteria.
CDI toxin-immunity protein complexes are excellent targets for
methods development in the CASP competition, because the activities
of most toxins are unknown and their interactions with cognate immu-
nity proteins are not easily predicted. Over the past several years, we
have taken complementary biochemical and structural approaches to
identify CDI toxin activities and explore the diversity of their interac-
tions with immunity proteins.39-43 We recently solved the crystal
structures of CdiA-CT•CdiI complexes from E. coli 3006 (EC3006) and
K. pneumoniae 342 (Kp342) at 2.20 and 2.55 Å resolution. The CdiA-
CTEC3006 toxin consists of a globular α/β core and an extended
α-helical subdomain (Figure 5A). The core is composed of two
3-stranded antiparallel β-sheets that interact in parallel and wrap
around helix α5, which forms the spine of the subdomain (Figure 5A).
The extension subdomain comprises three α-helices that mediate
many of the direct contacts with CdiIEC3006 (Figure 5A). CdiA-CTKp342
shares a number of structural elements with the CdiA-CTEC3006 core;
though the CdiA-CTKp342 domain lacks the N-terminal β-sheet, and its
C-terminal β-sheet consists of four strands (Figure 5B). Further, the
α-helical extension subdomain is abbreviated to one helix and a loop
in CdiA-CTKp342. Though the toxins share significant structural homol-
ogy, the immunity proteins have completely unrelated structures.
CdiIEC3006 is an α-helical monomer that adopts an α-solenoid fold
(Figure 5A), whereas CdiIKp342 forms a dimeric β-sandwich (Figure 5C).
The structures reveal that both toxins are members of the barna-
se/EndoU/colicin E5-D/RelE (BECR) superfamily of RNases,44 though
they exhibit no detectable sequence similarity to BECR enzymes and
are not annotated as such. DALI identifies the C-terminal nuclease
domain of colicin D as the closest structural homolog of CdiA-
CTKp342. CdiA-CTKp342 residues Lys157, Tyr160, and Thr255 superim-
pose onto the active site residues of colicin D. Furthermore, CdiA-
CTEC3006 contains a similar triad of Lys204, Tyr208, and Thr330
arranged in the same configuration. The toxins also share conserved
Arg and His residues that could play roles in binding substrate and
catalysis. Previous activity studies have shown that CdiA-CTEC3006
specifically cleaves tRNAIle molecules,45 indicating that the toxin is
indeed a BECR family RNase. Notably, the CdiI proteins both bind
over the predicted active sites of their cognate toxins (Figure 5A,B),
indicating that the immunity proteins neutralize toxicity by blocking
access to RNA substrates.
For the CASP13 competition, the components of each CdiA-
CT•CdiI complex were first modeled as monomers, and the top
F IGURE 4 Crystal structure and models for LP1413. A, Ribbon diagram of the crystal structure, shaded from blue (N-terminal) to red (C-
terminal). B, The crystal structure from a slightly different viewpoint, with a transparent molecular surface showing the hydrophobic pocket (roughly
center) and the conserved Proline residues of the helix 3––strand 2 turn shown as sticks. C, Superposition of the top 40 predicted models (wall-eyed
stereo), from the same viewpoint as in panel A. The two chains from the asymmetric unit of the crystal structure are shown in black
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10 predicted models according to GDT-TS were evaluated (Table 1,
Target: H0957). For CdiA-CTEC3006, the best five predictions have
GDT-TS scores ranging from 49.07 (T0957s1TS043_4) to 45.22
(T0957s1TS043_1). These models predict the existence of the C-
terminal β-sheet, the spine α-helix, and the α-helical extension sub-
domain (Figure 5D). The N-terminal β-sheet and following α-helix of
CdiA-CTEC3006 are positioned incorrectly, displacing the C-terminal
β-sheet from its position in the experimental structure. This results in
the high global deviation for the top model T0957s1TS043 with a
GDT-TS of 49.07 (Cα RMSD = 13.80 Å); local agreement of 1.77 Å is
attained for only 47% of residues within a 5 Å distance cutoff. The
sixth model (T0957s1TS117_4, GDT-TS = 39.97 and RMSD = 10.69 Å)
includes the α-helical extension, but fails to capture the core α/β sub-
domain. Neither of the β-sheets is properly generated, and the two
α-helices are not positioned correctly. The remaining four models are
essentially identical (GDT-TS = 38.73) and bear little similarity to the
experimental structure. Finally, none of the models arrange the puta-
tive active site residues properly.
The top 10 CdiA-CTKp342 models are very similar to one another
and more accurately reflect the experimental structure (Table 1, Target:
H0968; Figure 5E), with GDT-TS scores ranging from 77.54
(T0968s1TS043_4-D1, global RMSDCα 5.04 Å) to 69.92
(T0968s1TS043_2-D1, global RMSD 4.53 Å). Some deviations are
observed at the N-terminus and the protruding α-helix (Figure 5E).
Locally, the top model aligns within 1.71 Å over 85% of residues. These
results suggest that the structure of the isolated CdiA-CTKp342 toxin
domain is very similar to that observed in complex with CdiIKp342.
The CdiIEC3006 models mirror the crystallographic structure quite
well, with GDT-TS scores of 65.32 to 60.65. All of the models feature
consecutive α-hairpins and differ only in the placement of the C-
terminal α-helix and the α1-α2 loop, for which none of the models
show good alignment with the target (Figure 5F). We note that the
positions of these latter elements may be constrained through interac-
tions with the CdiA-CTEC3006 toxin domain. The top model
(T0957s2TS043_5-D1, GDT-TS = 65.32) yields an overall Cα RMSD of
4.15 Å and local of 2.11 Å over 68% of residues.
More accurate predictions were obtained for CdiIKp342, with the
10 best models scoring GDT-TS of 78.70 to 71.30. As with CdiIEC3006,
the major deviations were localized to the N- and C-terminal regions,
which the top model (T0968s2TS043_1-D1; GDT-TS = 78.70, 2.33 Å
global Cα RMSD and 1.77 Å over 96% residues) misrepresents as helical
turns (Figure 5G). It is the third model (T0968s2TS214_2-D1; GDT-
TS = 77.39, 2.05 Å global Cα RMSD and 1.81 Å over 92% residues) that
correctly predicts a random coil and a β-strand at the termini. Again, the
latter section is in close proximity to the toxin domain in the complex
structure.
As we found during CASP12, the prediction of protein-protein bind-
ing interfaces remains a significant challenge. Even with decent mono-
meric models and supporting information from SAXS and cross-linking
data for CdiA-CT•CdiIKp342, no meaningful theoretical complex was
F IGURE 5 A, Experimental structure of CdiA-CT•CdiIEc3006. The CdiA-CTEc3006 toxin domain is shown in yellow with functionally important
residues shown in stick representation. The CdiIEc3006 immunity protein is shown in gray. B, Experimental structure of the CdiA-CT•CdiIKp342
(heterodimer) with CdiA-CTKp342 shown in red and CdiIKp342 in gray/black. C, Experimental structure of the CdiA-CT•CdiIKp342 (hetero-tetramer)
with CdiA-CTKp342 shown in red and CdiIKp342 in gray/black. D, Superposition of CdiA-CTEc3006 (yellow) with T0957s1TS043_4 (green). E,
Superposition of CdiA-CTKp342 (red) with T0968s1TS043_4-D1 (green). F, Superposition of CdiIEc3006 (gray) with T0957s2TS043_5-D1 (blue). G,
Superposition of CdiIKp342 (gray) with T0968s2TS043_1-D1 (blue) and T0968s2TS214_2-D1 (purple)
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generated. This is perhaps because the best monomer predictions were
not used to predict the complex structure. For example, CdiA-CTKp342
from the highest scoring CdiA-CT•CdiIKp342 model (H0968TS208_4)
ranked 114th in the individual subunit calculations, with a GDT-
TS = 55.09. Another model of a complex, H0968TS163_2, features rea-
sonably good CdiA-CT (T0968s1TS163_1-D1, GDT-TS = 69.28), and
wrongly predicted CdiI (T0968s2TS163_2-D1, GDT-TS 42.39), even
though the same group had a much better model in their repertoire
(T0968s2TS163_4-D1, GDT-TS = 61.74). Generally, oligomeric predic-
tions vary enormously and the algorithms struggle to identify the proper
interacting surfaces. Analysis of any structural details and their func-
tional implications appears to be beyond the reach of current computa-
tional approaches, at least for these particular targets.
2.6 | A putative ACAD from B. bacteriovorus (CASP:
T0961, PDB: 6SD8 (Apo form), PDB: 6SDA (Holo
form)). Provided by Christopher J. Harding and
Andrew L. Lovering
Acyl-CoA dehydrogenases (ACADs) are a large and important class of
metabolic enzymes with diverse functions. ACADs typically catalyze
the α,β-dehydrogenation of various CoA-fused substrates, linked to
the β-oxidation cycle and amino acid metabolism.46 In contrast to tra-
ditional roles, recent studies have highlighted a number of ACAD
homologs that have important physiological functions beyond β-oxi-
dation, such as responses to environmental stresses, DNA repair, and
adaptation to heat.47-50
Here we investigated a putative ACAD, Bd2924, from the obligate
predatory bacterium, B. bacteriovorus. Our initial interest arose in
Bd2924 when it was first identified as a potential novel cyclic di-GMP
(cdG) interacting protein.51 CdG is an almost universally important
bacterial secondary messenger molecule influencing growth and a
range of behaviors such as motility, virulence, biofilm formation, cell
cycle progression and (in Bdellovibrio) control of predation.52
We determined the structure of Bd2924 (residues 3 to 505) in
complex with the cofactor FAD, with and without a C10 length acyl-
CoA thioester ligand (C10-CoA) bound, to 1.51 and 1.87 Å respec-
tively (Table 1, Target: T0961). The tertiary structure of Bd2924 forms
a biologically relevant homo-tetramer, composed of a dimer of dimers,
which was later confirmed to be the predominant species in solution
by size exclusion chromatography experiments. Bd2924 shares the
common ACAD fold,53 and is most closely related to the divergent
ACADs, AidB, and ACDH-11.49-53 Bd2924 can be divided into four
distinct domains: an N-terminal α-helical domain that is interrupted by
a single β-sheet projection (residues 3-168), a central β-sheet domain
formed by two orthogonal four-stranded antiparallel β-sheets (resi-
dues 169-285), a central α-helical domain (residues 286-449) and a
short C-terminal α-helical domain (residues 450-505) (Figure 6A). A
single FAD molecule binds per monomer in a crevice located at the
dimer interface. The Bd2924:C10-CoA complex provided structural
insights into the interactions Bd2924 makes with its substrate. The
C10-CoA ligand bound into a long narrow tunnel that runs deep into
the protein beneath the bound FAD molecule, similarly to that
described for other ACAD structures.46-53 Interestingly, only one mol-
ecule of C10-CoA per dimer could be confidently placed into the elec-
tron density maps, which corresponded to the conformation of
Trp428 beneath the re-face of the FAD molecule. In our structures,
Trp428 appears to gate accessibility for the acyl moiety (Figure 6C).
Analysis of Bd2924 did not reveal any conventional cdG binding sites
in the structure, nor was a cdG complex obtainable. Further biophysi-
cal binding experiments were conducted, which suggested weak non-
specific binding between cdG and Bd2924 (data not shown).
The tetrameric assembly of divergent ACADs appears to block the
proposed docking site of electron transferring flavoprotein (ETF).54,55
Interestingly, we were unable to detect any dehydrogenation activity;
likewise no significant dehydrogenase activity has been reported for
other divergent ACADs.49,51-56 Moreover, the structure of Bd2924
reveals that the chemistry of the conserved active site residue Glu429
may be altered by participating in a hydrogen bond with Asn171. Typ-
ically a hydrophobic residue such as phenylalanine is found at the
position of Asn171 in “conventional” catalytically active ACADs.
Bd2924 was included in CASP13 as target T0961 and also selected
for CAPRI experiments. In general, models predicted the overall fold of
Bd2924 to a high standard and included most of the main features iden-
tified from our crystal structure (Figure 6B). This may not be entirely
surprising, considering the highly conserved fold within the ACAD
superfamily and the presence of highly similar homologs (AidB and
ACDH-11) in the PDB that could act as templates. Notably, the models
were able to correctly predict the structural features of divergent
ACADs and the tetrameric assembly. The models also predicted the
large groove in the C-terminal domain, which was a noteworthy feature
of Bd2924s structure. A loop region (residues 191-202) contained the
least similarity to our experimental structure and had the most variabil-
ity in the top models. This is likely due to the loop being a relative inser-
tion in the primary sequence of Bd2924 in comparison to templates
AidB and ACDH-11. Specifically, models deviated around the ligand
binding and active site regions (Figure 6D). For instance, the modeled
conformation of Trp428 obstructs the depth of the substrate-binding
tunnel, which would lead to incorrect predictions about the length of
fatty acyl chains that can be accommodated. Furthermore, the strictly
conserved catalytic glutamate residue, Glu429, is also modeled in vari-
ous conformations. Our crystal structure highlighted a potentially
important hydrogen bond between Glu429 and Asn171, which may
explain the lack of observable catalytic activity. However, none of the
top models successfully model the same hydrogen-bonding interaction
captured in the crystal structure. A major drawback to the models is the
lack of precision regarding Bd2924 interaction with its cofactor FAD,
which is an integral part of the structure of ACADs.53
2.7 | The receptor-binding tip (gp373-gp38) from the
Salmonella phage S16 long tail fiber (H0953, PDB ID:
6F45). Provided by Matthew Dunne and Petr
G. Leiman
Bacteriophages (phages), viruses that infect bacteria, have served as
indispensable tools for many generations of scientists, in particular for
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discovering the nature and structure of genetic material57,58 and more
recently for the discovery of the CRISPR system.59,60 Phages and their
component parts are also used as diagnostic tools and remediative
agents in food processing, biotechnology, and medicine (ie, phage
therapy).61-63 The majority of phages consist of an icosahedral “head”
(or capsid) containing a dsDNA genome, connected to a specialized
delivery organelle called the “tail” (Figure 7A). The tail provides selec-
tive recognition and attachment to suitable host cells, generating a
conduit between the capsid and the bacterial cytoplasm through
which the phage genome is delivered. The initial binding of phage to a
bacterial cell is mediated by fibers or stockier “tailspikes” proteins
emanating from a baseplate structure at the end of the tail. While
internal host defense systems (eg, CRISPR systems) can inhibit phage
infectivity, the spectrum of cell surface receptors to which fibers and
tail spikes recognize remains the primary determinant of host range
for phages. To this end, phage S16 is special as it can infect many Sal-
monella strains, suggesting that either S16 recognizes a wide assort-
ment of cell surface substrates, or S16 targets a highly conserved
receptor of Salmonella. S16 is a relative of the well-studied phage T4.
Both phages are equipped with baseplate-attached long tail fibers
(LTFs) that mediate receptor-binding through their distal tips.64-68 We
recently exploited the Salmonella-specific binding of the S16 LTF as a
tool for rapid, ELISA-like detection of Salmonella contaminants in
food.69
The T4 and S16 LTFs are similar to each except for the structure
of their distal tip that interacts with the host cell surface during host
recognition. The distal tip of the T4 LTF is formed by the C-terminal
domain of gene product 37 (gp37), whereas the S16 LTF carries an
additional protein––gp38 that caps gp37. Gene 38 is present in the
T4 genome, but the amino acid sequence of T4 gp38 is very different
from that of S16 gp38 and its function is to assist folding and assem-
bly of the T4 LTF. Ironically, the prototypical and better studied T4
phage in which gp38 does not participate in host recognition is a less
common representative of T-even phages most of which appear to
carry S16-like LTFs. Unsurprisingly, the structure and function of
gp38 and its homologs (commonly named “adhesins”70) have been of
great interest ever since they were discovered as the determinants of
phage host range.71 Thus, by solving the crystal structure of a distal
part of gp37 connected to gp38 from phage S16 we aimed to advance
our understanding of this important family of adhesins (Figure 7B).68
Gp37 is a homotrimeric β-helix. Five β-strands (β1 to β5) of each
chain form a concave, antiparallel β-sheet arranged into a three-sided
β-prism called a “triangular domain.” The following β6 to β9 maintain
the β-helix topology, however, successive strands alternate between
the three sides and form an “interdigitated domain.” The N-terminal
helical bundle (α1-α3) of gp38 attaches to the base of the interdigi-
tated domain through strong hydrophobic interactions. At the apex of
α1 to α3 are exposed tryptophan residues that insert every 120
F IGURE 6 A, Crystal structure of Bd2924 showing 4 distinct domains: a N-terminal domain α-helical domain (green, residues 3-168); a
central β-sheet domain (red, 169-283); a C-terminal α-helical domain (blue, 286-449) and a C-terminal extension domain (yellow, 450-505). FAD
cofactor (magenta) and C10-CoA ligand (cyan) are shown in spacefill. B, Superposition of Bd2924 crystal structure (blue) and the three best
models: T0961TS086_1 (yellow), T0961TS460_1 (green), T0961TS241_1 (red). C, A close-up view of the C10-CoA ligand binding site (cyan). The
CoA moiety makes 8 hydrogen bonds (black dashed lines) and other non-bonding interactions, while the fatty acyl chain inserts into a narrow
tunnel (gray surface). Access to the binding tunnel appears to be gated by the conformation of W428 (orange), which adopts two conformations;
one that allows access (C10-CoA present) and one that blocks access (C10-CoA absent). D, Comparison of the active site between Bd2924
crystal structure and the three best models (same coloring scheme as in Figure 6B)
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around the fiber axis into similar hydrophobic pockets on the sides of
the gp37 β-helix. These tryptophans and other hydrophobic interface
residues are conserved in the adhesins of phages targeting different
hosts, suggesting a preference for this mode of attachment in other
fibers. A short linker connects the N-terminal domain to a central five-
ringed β-helix. Here, all β-strands and turns align perpendicularly to
the fiber axis. Strikingly, the two turns connecting β5 to β6 and β8 to
β11 of the β-helix (18 and 77 residues, respectively) extend along the
fiber axis and form the distinct, three-layered “polyglycine sandwich”
domain. Over 50% of residues within this domain are glycines (37 out
of 73 residues) distributed between 10 glycine-rich motifs (GRMs)
separated by short hypervariable segments (HVSs). The GRMs all form
left-handed, elongated helices of a rare polyglycine type II (PGII) dispo-
sition (Figure 7C) with similar properties to polyproline type II (PPII)
helices, as found in collagen.72 The shorter β5 to β6 extension forms
the first two helices (1-2) and the longer β8 to β11 extension gener-
ates the last eight helices (3-10). Connecting the helices are the HVSs
that form short β-turn loops at both ends of the domain. Interestingly,
sequence variability within the five distal HVS loops (Figure 7C)
directly relates to host range adaptation, and is therefore where we
propose receptor binding occurs.
To the best of our knowledge, only four other structures in the
PDB contain similar PGII motifs; however, none of them feature long
GRMs (eg, helix 3; 151-GGGGGGGG-158) or form similar lattices as
the polyglycine sandwich. The absence of similar structures within the
PDB makes the polyglycine sandwich an especially difficult domain to
predict. As expected, the combination of this structurally unique
domain and the unusual composition of the (gp37)3-gp38 complex,
particularly the trimer-monomer interface, proved an especially chal-
lenging target in CASP (Table 1, Target: H0953). For instance, gp38
alone was modeled poorly and only the top prediction,
T0953sTS498_1 by the RaptorX-contact group, produced a GDT-TS
score > 40. Nevertheless, upon visual inspection the top three predic-
tions all roughly determined the correct gp38 topology and its three
distinct domains. As shown for the top model (Figure 7E), the central
β-helix is predicted quite well and includes the capping α-helix (α4) as
well as the important two loop extensions that form the polyglycine
sandwich in the crystal structure. Interestingly, in this model the loops
generate a similar sandwich-like structure, which correctly features
connecting β-turn loops at either end; however, the intricate lattice
composition of the polyglycine sandwich is missing. As seen with this
model, the gp38 central β-helix as a single target (T0953s2-D2) was
also generally predicted well, with 37 out of 90 predictions generating
GDT-TS scores >40.
The highest ranked model for the whole gp37-gp38 multimer was
TS086_1 by the BAKER group (Figure 7F) with a QS-score of 0.37.
Despite failing to predict gp38 and its attachment to gp37 correctly,
this model very accurately determined the composition of the gp37
β-helix, including the N-terminal triangular and C-terminal interdigi-
tated domains. As a single target, gp37 (T0953s1-D1) was similarly
predicted well, with the top two models by groups A7D and BAKER
(GDT-TS of 54.48 and 48.88, respectively) shown in Figure 7D. Visual
F IGURE 7 The adhesin tip of the Salmonella phage S16 long tail fiber. A, Transmission electron micrograph of phage S16 with arrows
(1) pointing to the approximate location of gp38 at the tip of the LTF and (2) pointing to the baseplate. B, Cartoon representation of the LTF distal
tip complex of homotrimeric gp37 β-helix (cyan, magenta, pink) attached to a single gp38 adhesin (gray) with the structurally unique “polyglycine
sandwich” domain rainbow colored (blue to red). Gp38 connects to gp37 through hydrophobic interactions, involving three highly conserved
tryptophan residues on the apex of each α-helix of the gp38 attachment domain (yellow sticks) that occupy three symmetry-equivalent
hydrophobic pockets on the gp37 base. C, Head-on view of the polyglycine sandwich domain formed by the 10 glycine-rich motifs (GRMs) of
gp38 folded into a three-layered lattice of PGII helices. Labeled are the five distal loops formed by HVSs that form the (yet unknown) receptor-
binding site(s) of gp38. Highlighted by the dashed box is a cartoon representation of the saturating hydrogen-bonding network of the central
GRM 3 with main-chain carbonyl (CO) and amide (NH) moieties of neighboring helices. D, Superposition of the two best model predictions of
monomeric gp37 (T0953s1-D1) by groups A7D (GST_TS: 54.48) and BAKER (GST_TS: 48.88). E, Cartoon view of the best prediction for
monomeric gp38 with residues expected to form the distal polyglycine sandwich rainbow colored (GST_TS: 40.12). F) The overall best prediction
for the whole gp37-gp38 multimer (QSglobal: 0.368, BAKER group). Panel A is reproduced with permission from Dunne M, Denyes JM, Arndt H,
Loessner MJ, Leiman PG, Klumpp J. Salmonella phage S16 tail fiber adhesin features a rare polyglycine rich domain for host recognition. Structure.
2018;26(12):1573-1582 e1574
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inspection showed correct prediction of the triangular domain; how-
ever, only the BAKER group correctly determined the continuation of
the gp37 chain to form the interdigitated domain. Interestingly, the
next eight best predictions also correctly modeled the triangular
domain, but similar to A7D, incorrectly assumed that the C-terminal
part folds back on itself. Possibly, the trimeric nature of the protein
was not taken into account for many of these predictions.
To assist the predictions, SAXS and SANS envelopes as well as
protein cross-linking data of the complex were provided to the com-
petition (S/A/X0953). The molecular envelopes generated by SAXS
and SANS reproduced the shape of the gp37-gp38 crystal structure
very well; however, it is unclear whether and how these data were
used by the CASP participants as the composition of predicted models
did not made biological sense or present folds similar to the crystal
structure. In fact, models obtained during the regular prediction round
without using these envelopes better represented the crystal struc-
ture. Due to a lack of potential cross-linking reactive residues (Lys,
Asp, and Glu) within the gp37-gp38 interface, protein cross-linking
was unfortunately not of assistance with oligomeric predictions.
2.8 | Pentafunctional AROM Complex from
Chaetomium thermophilum (CASP: T0999, PDB: NA).
Provided by Harshul Arora Veraszto and Marcus
D. Hartmann
The AROM complex is a homodimeric pentafunctional fusion enzyme
in the shikimate pathway in fungi and protists.73 This pathway is a
seven-step biosynthetic route to chorismate, the central precursor for
aromatic amino acids and other aromatic compounds,74 and a textbook
drug target for being essential in prokaryotes and lower eukaryotes, but
absent from metazoa. Most prominently, it is the target of glyphosate,
the active ingredient of Monsanto's ubiquitous blockbuster weed-killer
Roundup.75 While most organisms have the seven steps of the pathway
encoded as individual, monofunctional enzymes, fungi, and protists
have the five central steps fused in the pentafunctional AROM poly-
peptide. These five steps comprise the 3-dehydroquinate synthase
(DHQS),76 3-dehydroquinate dehydratase (DHQD),77 shikimate dehy-
drogenase (SD),78 shikimate kinase (SK),79 and 5-enoyl-pyrovyl-
shikimate-3-phosphate synthase (EPSPS)80; in AROM, they are fused in
the order N-DHQS-EPSPS-SK-DHQD-SD-C. Homodimerization of
AROM was expected to be mediated by its DHQS domain, which is an
obligate homodimeric enzyme, and possibly by its type I DHQD
domain, which typically forms homodimers as well. Although the struc-
tures of the monofunctional homologs of the constituent domains are
studied in great detail in prokaryotes and plants, the fungal AROM com-
plex has so far withstood structural analysis at molecular detail.
We had recently set out for a new approach to study AROM's
structure and function, making use of the thermophilic eukaryotic
model organism Chaetomium thermophilum (Ct). CtAROM (UniProt:
G0S061) turned out to be a well-behaved and stable homodimer of
about 340 kDa (Table 1, Target: T0999). As we did not expect a fast
breakthrough in crystallization experiments, we started to equip our-
selves with experimental restraints for an in silico structure modeling.
To this aim, we collected small angle X-ray scattering (SAXS) data and,
in collaboration with Alexander Leitner from ETH Zürich, cross-linking
mass-spectrometry (XL-MS) data, which we aimed to combine for a
rigid-body modeling and refinement approach based on the known
structures of the individual enzymatic domains (see also81). However,
we indeed obtained well-diffracting crystals quite early on and thus
focused on crystallographic structure solution. Finally, the crystal struc-
ture revealed a very compact assembly of the 10 domains, with the
expected homodimeric DHQS and DHQD domains at the center
(Figure 8). All individual domains exhibit the structure expected for their
monofunctional counterparts, and the enzymatic domains catalyzing
consecutive steps of the pathway are found in close proximity to each
other.
Although not used for initial structure determination, the SAXS and
XL-MS data turned out to be very insightful in investigating the confor-
mational landscape of the AROM complex (to be published), which
motivated us to provide both our SAXS and XL-MS data to CASP par-
ticipants. Obviously, the prediction of the individual domains was a triv-
ial task, and was mastered very well by most of the participating groups
(average best GDT-TS over D2-D5 domains = 80.39). When it came to
the prediction of the whole assembly, however, the situation was quite
F IGURE 8 Crystal structure of the dimeric AROM complex in top,
side (enlarged), and bottom view, with the five constituent enzymatic
domains colored individually. In the side view, the domains are labeled
on the left half of the dimer, on the right half the succession of
metabolic steps is illustrated by an arrow, indicating the path DHQS-
DHQD-SD-SK-EPSPS
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different. Although a number of predicted interdomain interfaces come
close-to what is observed in the crystal structure, it is hard to score the
outcome in a quantitative fashion. For many predictions, individual pairs
of domains that are consecutive in sequence are docked in a roughly
correct orientation, but the transition from these roughly correct to
clearly wrong orientations is smooth, and there is barely a prediction
having three domains docked correctly per monomer. Notably, while
the majority of the groups correctly constrained the DHQS domain to
form the obligate homodimer, almost none of the participants put the
respective constraint on the DHQD domain. We expect that this addi-
tional constraint would have helped in most cases to guide the assem-
bly into the direction of the crystal structure. Overall, as no group could
predict the AROM complex to an accuracy that reasonably reflects
close-to-correct relative orientations of its constituent domains, we
cannot clearly nominate the better predictions. It is noticeable, how-
ever, that the SAXS-assisted predictions yielded the optically overall
most-native-looking model, TS008_1 from the Pierce group, which also
yielded the seventh best GDT-TS score (22.9) and the third best global
RMSD to the crystal structure: 27.9 Å. A detailed description of data
assisted modeling results is provided in a dedicated chapter of this spe-
cial issue.
2.9 | Apical end cap and needle of the antifeeding
prophage (AFP) from S. entomophila and its threefold
symmetric needle (CASP: H1021, PDB: 6RAP; CASP:
H1022, PDB: 6RBK). Provided by Ambroise Desfosses,
Alok Mitra, and Irina Gutsche
Contractile injection systems (CISs) such as contractile bacteriophage
tails, the Type VI secretion system (T6SS), R-pyocins, and tailocins are
multiprotein injection devices sharing a seringe-like architecture.82-84
They are assembled of three major building blocks: a long rigid inner
tube sharpened by a needle-like tip, a contractile helical sheath sur-
rounding the tube, and a baseplate that anchors the system to the tar-
get cell membrane, rearranges and triggers sheath contraction to
expel the tube out of the sheath and puncture the target membrane.
The two targets provided to CASP were derived from the high-
resolution cryo-electron microscopy (cryo-EM) structures of the anti-
feeding prophage AFP from the soil bacterium S. entomophila whose
pathogenicity to the New Zealand pasture pest Costelytra giveni, is
largely due to AFP which injects its insecticidal toxin into the C. giveni
larvae.85 The targets represent the two opposite extremities of the
AFP tailocin in its metastable extended state: the cap (Table 1, Target
H1021) and the needle (Table 1, Target H1022).
F IGURE 9 The apical cap of
the AFP particle in extended
state. A,B, Experimental structure
of the H1021 target and the five
best CASP prediction models
according to QS score. This
hexameric complex is composed
of one layer of the sheath protein
Afp2 (blue) surrounding the tube
protein Afp1 (dark green) and
capped by Afp16 (shades of
magenta). The N- and C-terminal
arms of Afp2 are shown in light
green and red, respectively. The
α-helix of Afp2 interacting with
the tube is shown in orange. The
ring-forming α-helix 148 to 156 is
shown in black. C, Afp1-Afp2
dimeric models are aligned to the
target (black). D, Monomer
predictions for Afp16, both for
domain 2 only (up) and for the
whole protein (bottom). EF,
Monomer predictions for Afp2
and Afp1, respectively
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The cryo-EM map of the first target (H1021), determined at an
average resolution of 3.3 Å, corresponds to the sixfold symmetric api-
cal end cap. This structure shows how the cap protein Afp16 (subunit
3 of H1021) binds to the inner tube protein Afp1 (subunit 1) and the
sheath protein Afp2 (subunit 2) to tightly stabilize the tube and pre-
vent toxin egress through the wrong extremity. Although homologous
structures of the tube and sheath proteins in related injection systems
such as the bacteriophage T486 and the R-pyocin87 had been solved,
at the time of the CASP competition the cap protein Afp16 had no
known structural homolog for the entire sequence length, and there-
fore represented a potentially difficult target for ab initio modeling.
Accordingly, the predicted models of the Afp1-Afp2-Afp16 complex
show a good accuracy for the Afp1-Afp2 sub-complex (Figure 9A,B).
The conserved interface formed between the sheath and the tube
(Afp2 α-helix-Afp1 ß-sheets) was correctly modeled by the top predic-
tions sorted by QS score (Figure 9C). The conserved bilobe fold of
Afp2, described for other CIS sheath proteins, was accurately
modeled in the monomer predictions (Figure 9E). In the complex,
intra-Afp2 interactions via the extended N- and C-terminal arms are
present in three out of five top models, although the monomer predic-
tions for Afp2 showed a C-terminal extension folded back onto the
upper lobe of Afp2 (Figure 9E).
The tube proteins Afp1 has a similar fold as the T4 (gp19,67) the
T6SS Hcp,88 and the R-pyocin tube protein,87 predicted with high
accuracy at the monomer level with GDT-TS > 70 (Figure 9F). At the
apical end, in the cap-bound state, the N-terminal Afp1 α-helix
unfolds to accommodate the interaction with Afp16 and to follow the
Afp16 interdomain linker (Figure 9F). Interestingly, although the
predicted models of the Afp1 monomer show an N-terminal α-helix as
observed in related tube proteins and in the tube conformation of
Afp1, several models of the whole complex presented a partially
unfolded helix as in the cap conformation (Figure 9F, TS068).
In the complex, the position and interaction surfaces of the cap
protein Afp16 were not precisely determined by the CASP prediction
models (Figure 9A), likely due to the modular organization of this pro-
tein. Afp16 is composed of two distinct domains linked by a long loop,
and forms a hexameric ring at the apex of the CIS trunk. The N-
terminal domain constitutes an extra layer of the tube while the C-
terminal domain caps the sheath (Figure 9A). CASP prediction models
for Afp16 monomers show good accuracy for the N- and C-terminal
domains individually, but failed to predict their relative position
(Figure 9D). The N-terminal domain of Afp16 possesses a short
α-helix (148-156), which organizes in a tight ring of 9 Å in diameter
that constricts the extremity of the particle upon Afp16
hexamerisation (Figure 9B). While several models correctly placed this
helix toward the middle of the complex, the predicted interaction was
less tight than observed in the target (Figure 9B).
The second target (H1022) corresponds to the threefold symmet-
ric structure of the AFP needle. The original cryo-EM map
encompassing three copies of the needle protein Afp8 (Figure 10, sha-
des of orange) and six copies of the tube initiator Afp7 (Figure 10, sha-
des of blue), was solved to an average resolution of 3.4 Å.
F IGURE 10 The needle of the
AFP particle. Experimental structure
of the target H1022 and the five best
CASP prediction models according to
QS score are shown in side view (top
left), top view (top right), and as a
slice through the region indicated by
dashed lines in upper panel,
corresponding to the threefold to
sixfold adaptor domain of Afp8
(bottom, dashed circle). The six copies
of Afp7 are shown as shades of blue,
while the three copies of Afp8
forming the needle are shown in
shades of orange. Orange arrows
indicate the disruption of the ß-helical
wall observed in several CASP
prediction models
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Reminiscent of T4 and T6SS, an important feature of the needle hub
are the twin ß-barrel domains of Afp8 which have a fold similar to the
core domain of the tube proteins (Afp1, Afp7 N-terminal domain).
Their arrangement creates a pseudohexameric layout67,89 which,
accommodates the transition from the hexameric ring formed by the
tube initiator Afp7 to the C3-symmetry of the rest of the Afp8 needle
trimer (Figure 10, dashed circles). In the predicted models, the
hexameric nature of this transition is not well respected, showing
rather a triangular organization. Another important feature of this tar-
get is the tapered needle at the bottom of Afp8 with an intercalated
ß-helical wall analogous to the T4 gp589 and T6SS VgrG/VgrG1,82 but
notably shorter. This feature was well reproduced by the CASP predic-
tion models, although most of them showed a disruption of the ß-
helical wall toward the bottom of the needle (Figure 10, orange
arrows). Globally, the conserved fold of Afp8 was accurately modeled
in the predictions. The structure of Afp7 was well predicted for the
core N-terminal domain at the interface with Afp8, whereas the posi-
tion and the fold of the C-terminal domain could not be modeled
correctly.
2.10 | Structure of a glycoside hydrolase family 31
α-xylosidase in complex with a cleaved xyloglucan
oligosaccharide (CASP: T1009; PDB: 6DRU). Provided
by Hongnan Cao, Jonathan D. Walton, and George
N. Phillips, Jr
Xyloglucan is a major hemicellulose of plant cell walls.90,91 Cellulose
and hemicellulose represent valuable biomass resources for renewable
lignocellulosic biofuel production.92 A bottleneck to this process, that
is, biomass recalcitrance, is the natural resistance of plant cell walls to
microbial and enzymatic deconstruction.92 To overcome this, various
enzymatic cocktails have been developed by DOE funded Bioenergy
Research Centers and others for efficient and eco-friendly conversion
of these naturally abundant polysaccharides into readily fermentable
sugar units. Walton's group at the DOE Great Lakes Bioenergy
Research Center (GLBRC) have previously demonstrated that
α-xylosidase from Aspergillus niger (AxlA) enhances yields of mono-
meric sugars glucose and xylose from xyloglucan and hold promise in
industrial lignocellulose conversion.90,91 In order to elucidate the
molecular basis of its catalytic function and substrate specificity, we
determined the crystal structure of recombinant AxlA in complex with
its catalytic product (Table 1, Target T1009; PDB: 6DRU), a xyloglucan
fragment at 2.7 Å resolution via molecular replacement using a struc-
ture of an α-glucosidase (PDB: 4B9Y)93 in the same glycoside hydro-
lase family 31 (GH31, www.cazy.org94) as AxlA.
The structure shows an overall typical GH31 enzyme fold with
two structurally conserved putative catalytic residues residing in a
central (β/α)8 barrel catalytic domain flanked by two β sandwich
domains at N- and C-termini (Figure 11A). The putative nucleophile
and general acid residues Asp395 and Asp487 locate on the opposite
sides of the catalytic labile C1 position of the xylose at −1 site cleaved
from the branched xyloglucan fragment. The averaged distances
between the carboxylic oxygen atoms are 6.38 and 6.55 Å for the two
structurally similar copies of the molecules in the asymmetric unit,
respectively. These values are consistent with a retaining catalytic
mechanism involving double displacement steps.95
The amino acid sequence of AxlA (UniProt ID: G3XMN9), without
the N-terminal peptide 50-MYFSSFLALGALVQAAAA-30, was submitted
to CASP13 for both regular target and oligomeric structural predictions.
The highest sequence identity of existing homologs to AxlA in PDB is
~28%. The top 4 ranked predicted models of AxlA as a regular target are
from prediction participants MUFold (GDT-TS = 71.24), Jones-UCL
(GDT-TS = 71.20), wfAll-Cheng (GDT-TS = 69.08), and Zhang (GDT-
TS = 68.38). To our surprise, most overall top-ranked teams like
AlphaFold A7D (GDT-TS = 60.97), QUARK (GDT-TS = 64.10), and MUL-
TICOM (GDT-TS = 67.13) are out of top 10 in this particular case, except
Zhang. We also noticed that the overall fold and locations of the two pro-
posed catalytic residues of AxlA is successfully predicted by most top
ranked models. However, not a single predicted model is able to repro-
duce the experimentally determined loop-helix-loop motif structure (resi-
dues 398-425), which appears to be structurally essential for AxlA to
form +1 site for the backbone glucose as well as recognizing galactose
and xylose sugars on the adjacent branch of the xyloglucan fragment
being acted on (Figure 11B,C). This is possibly due to the low sequence
and structural conservation in this region in structurally characterized
GH31 enzymes, which comprise a wide variety of substrate
specificities according to www.cazy.org,94 including α-glucosidase (EC
3.2.1.20); α-galactosidase (EC 3.2.1.22); α-mannosidase (EC 3.2.1.24);
α-1,3-glucosidase (EC 3.2.1.84); sucrase-isomaltase (EC 3.2.1.48) (EC
3.2.1.10); α-xylosidase (EC 3.2.1.177); α-glucan lyase (EC 4.2.2.13); iso-
maltosyltransferase (EC 2.4.1.-); α-1,4-glucosyltransferase (EC 2.4.1.161);
sulfoquinovosidase (EC 3.2.1.-). The shape and interactions complemen-
tarity between the enzyme pocket and the xyloglucan fragment provides
further evidence on its substrate specificity and suggests its usefulness in
lignocelluloses deconstruction (Figure 11C).
A close examination on the quaternary assembly of AxlA using
EPPIC96 identified it as a possible homo-tetramer formed from two sub-
units in the asymmetric unit and two adjacent subunits related by crystal-
lographic symmetry. The above-mentioned loop region with poor
structural predictions is also involved in tetrameric assembly (Figure 11D).
This can be one of the factors that lead to the relatively poor predictions
of AxlA as oligomeric target, with the top ranked model from BAKER
team giving a QS-score of only 0.177 for the dimer interface.
2.11 | Structure of A. thaliana xylan O-
acetyltransferase 1 (CASP: T0969, PDB: 6CCI).
Provided by Markus Alahuhta, Vladimir V. Lunin, and
Yannick J. Bomble
A. thaliana xylan O-acetyltransferase 1 (AtXOAT1) is a plant-specific tri-
chome birefringence (TBL) like enzyme that catalyzes the 2-O-acetylation
of the xylan backbone.97 Structural characterization of AtXIAT1 is part of
a wider effort to elucidate the molecular basis of polysaccharide biosyn-
thesis and biomass modifications by different plant-derived enzymes,
including glycosyltransferases, acetyltransferases, and methyltransferases.
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The crystal structure of the AtXOAT1 was determined by single
wavelength anomalous dispersion method using anomalous signal
from sulfur atoms (S-SAD) at CuKα wavelength (Table 1, Target:
T0969). The structure is composed of three β-sheets consisting of
seven (β3-β6, β9, β12-β13), four (β7-β8, β10, β11), and two (β1-β2)
β-strands, respectively, nine α-helices including a “broken” one and
three α-helical turns (Figure 12A). The molecule is divided into two
lobes with a deep cleft in between: the first larger lobe contains
almost all secondary structure elements found in the protein while the
second, of smaller size, is mostly unstructured and contains four disul-
fide bridges (Cys140-Cys191, Cys162-Cys227, Cys171-Cys467,
Cys384-Cys463). The deep cleft between the two lobes contains the
substrate binding site, that is, a catalytic triad Ser216-His465-Asp462
similar to that found in serine proteases98 (Figure 12B). The walls of
the cleft are formed by two flexible loops (residues 443-448 and
273-281). Biochemical experiments with truncation mutants at the
N-terminal cytoplasmic tail, the predicted transmembrane domain and
the N-terminal variable region, identified the catalytic domain as the
region between residues 133 to 478.
The top two ranked models (T0969TS197_1-D1 and
T0969TS406_1-D1, from MESHI and Seder3mm groups, GDT-
TS = 58.19 and 57.49, respectively) correctly reproduced the overall
fold of AtXOAT1 (Figure 12A). Most deviations from the reference
structure (PDB: 6CCI) occur at the region surrounding residues 437 to
468 and at loops 262 to 284 and 312 to 334. The short β-strands
defined by residues 437 to 439 and 462 to 464 are also not reproduced
in the models. A closer inspection of the active site revealed an incor-
rect orientation of two of the three catalytic residues, namely Asp462
and His465, with a main-chain shift toward the top of the cleft and
overall RMSD of the active site residues of 3.7 Å and 4 Å, respectively.
This is accompanied by an incorrect flip of residues Trp309 and Trp466
into the active site.
The third ranked model T0969TS274_1-D1 (MUFold) showed
a slightly higher global deviation from the reference structure
F IGURE 11 A Experimental structure of the target H1022 and the five best CASP prediction models by QS score (one per participating
group) are shown in side view (top left), top view (top right), and as a slice through the region indicated by dashed lines in upper panel,
corresponding to the threefold to sixfold adaptor domain of Afp8 (bottom, dashed circle). The 6 copies of Afp7 are shown as shades of blue, while
the 3 copies of Afp8 forming the needle are shown in shades of orange.) Crystal structure of AxlA (PDB: 6DRU, chain A, color-coded by
secondary structures, helices in red, beta-strands in yellow, and loops in green) and superposition with the search model (PDB: 4B9Y, white)
shows conserved GH31 fold and putative catalytic residues (spheres). The cleaved xyloglucan oligosaccharide is shown as sticks with carbon in
green and oxygen in red. B, Structure superposition of AxlA with top CASP13 regular target predictions shows an overall agreement on fold (thin
ribbons) and conserved catalytic residues positions (spheres). A less conserved loop-helix-loop motif (cartoons) is poorly predicted and lacks
agreement. Top CASP13 models are color-coded as cyan (MUFold), pink (Jones-UCL), magenta (wfAll-Cheng), and Zhang (red) in the order ranked
by GDT-TS. Additional aligned models are in white (A7D), black (MULTICOM) and gray (QUARK), which are generated from top-ranked
prediction methods based on overall performance on all regular targets but outrun by others in AxlA predictions. C, A close-up view in surface
representation of AxlA substrate binding pocket with bound oligosaccharide product shown as sticks. Black dot surfaces indicate shape and
interaction complementarity between the enzyme and the ligand. The ligand +1 site and branched sugar units attached to the +2 site are
recognized by a pocket formed between the loop-helix-loop motif in yellow and an adjacent subunit in cyan. The catalytic labile α-glycosydic
bond is between the −1 site and + 1 site sugars. D, Tetrameric AxlA assembly predicted by EPPIC
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(GDT-TS = 52.83) but still captured the correct overall fold. Interest-
ingly, this model shows a slightly better local accuracy, with an RMSD
of the active site residues of 3.2 Å (Figure 12B). In summary, the top
three models all reproduced the overall fold and most of the second-
ary structure elements. They all had shifts in the position of the cata-
lytic residues but were close enough to be able to correctly identify
the location of the active site and identity of catalytic residues.
3 | CONCLUSIONS
This article provides insights into structural and functional details of
13 selected CASP13 targets and analyses to what extent the most
interesting features of the targets are reproduced in the models, as
illustrated by the author of the structures. The presented examples
highlight a series of recurring themes, reflecting both the success and
pitfalls of current prediction methods. On one hand, the ability of
predicting hard protein folds at the tertiary level has increased enor-
mously with the structure of many difficult targets reproduced with
impressive accuracy. On the other hand, important global and local
features of prediction models are still seldom as accurate as in the
experimental structure. This is the case of enzyme active sites and
ligand binding sites, where the predicted arrangement of the amino
acids side chains involved in ligand binding and substrate specificity
has not achieved the level of accuracy required to confidently infer
their function (i.e., T0961, T0957, T0969). Accurate prediction of
loops is still a challenging task. As they are often involved in PPIs, their
incorrect prediction can compromise the accuracy of the interacting
surface and overall structure of the complex. An example of this sce-
nario is highlighted in T1009, where a specific loop-helix-loop motif
appears to be essential for both catalytic activity and tetrameric
assembly of AxlA. A similar case is target H1021, where the incorrect
prediction of a long loop region leads to inaccurate domain orientation
of the Afp16 subunits. The latter example also points to an important,
re-emerging issue in CASP. That is, the ability of current methods in
modeling the correct quaternary structure of proteins remains rudi-
mentary and shows little progress compared to what observed at the
tertiary level. For example, while the majority of predictors success-
fully modeled the individual domains of the AROM enzyme (T0999),
no group was able to predict the correct assembly of the pen-
tafunctional complex. This represents an important drawback, as the
oligomeric state is often relevant for structural and functional integrity
of the target and may also assist predictions of the interdomain orien-
tation in multidomain proteins. As also highlighted in H0953, how-
ever, the oligomeric state of the target was possibly not taken into
account for predictions.
As assessing the functional relevance of models is difficult for
CASP assessors to address on a large scale, we hope that this study
will inspire future CASP assessors in emphasizing the relevant aspects
of models that inform our understanding of protein function.
ACKNOWLEDGMENTS
CASP experiment and open access fees for this manuscript are
supported by the US National Institute of General Medical Sciences
(NIGMS/NIH), grant number GM100482. T0970: The SGC is a regis-
tered charity (number 1097737) that receives funds from AbbVie,
Bayer Pharma AG, Boehringer Ingelheim, Canada Foundation for
Innovation, Eshelman Institute for Innovation, Genome Canada, Inno-
vative Medicines Initiative (EU/EFPIA) ULTRA-DD grant number:
115766, Janssen, Merck KGaA Darmstadt Germany, MSD, Novartis
Pharma AG, Ontario Ministry of Economic Development and Innova-
tion, Pfizer, São Paulo Research Foundation-FAPESP, Takeda, and
Wellcome: 106169/ZZ14/Z (to D.M.P., J.C.B., ANB). H0980: O.R.D. is
a Sir Henry Dale Fellow jointly funded by the Wellcome Trust and
Royal Society (Grant Number 104158/Z/14/Z) and is also supported
by a Royal Society Research Grant (Grant Number RG170118).
H0957, H0968: Grant sponsor: National Institutes of Health; Grant
number(s): GM102318 (C.W.G., C.S.H. and subcontract to A.J.); Grant
sponsor: National Institutes of Health; Grant number(s): GM117373
(to C.W.G. and C.S.H.); Grant sponsor: National Institutes of Health;
Grant number(s): GM094585 (to A.J.); Grant sponsor: National Insti-
tutes of Health; Grant number(s): GM115586 (to A.J.); Grant sponsor:
U. S. Department of Energy, Office of Biological and Environmental
Research; Contract number(s): DE-AC02-06CH11357 (to A.J.). T0961:
C.J.H. was funded by a BBSRC MIBTP studentship (1500753).
H0953: Grant sponsor: ETH Zurich; grant number: ETH-08 14-1.
T1009: Grant sponsor: U. S. Department of Energy, DOE Great Lakes
F IGURE 12 A, Superposition of the
AtXOAT1 crystal structure (green) and top
CASP13 model T0969TS197_1-D1
(magenta). B, A close-up view of the
active site showing the catalytic triad in
stick representation
18 LEPORE ET AL.
Bioenergy Research Center, DOE Office of Science, grant number:
BER DE-FC02-07ER64494 (to G.N.P. and J.D.W.). Grant sponsor:
National Institutes of Health, grant number: U01 GM098248
(to GNP). Grant sponsor: U. S. Department of Energy, Office of Sci-
ence, Office of Basic Energy Sciences, contract number: DE-
AC02-06CH11357 (to LRL-CAT beamline at Argonne National Labo-
ratory to use the Advance Photon Source for data collection). T0969:
Funding was provided in part by the BioEnergy Science Center (BESC)
and the Center for Bioenergy Innovation (CBI), from the
U.S. Department of Energy Bioenergy Research Centers supported by
the Office of Biological and Environmental Research in the DOE
Office of Science. This work was authored by the Alliance for Sustain-
able Energy, LLC, the Manager and Operator of the National Renew-
able Energy Laboratory for the U.S. Department of Energy (DOE)
under Contract No. DE-AC36-08GO28308. The views expressed in
the article do not necessarily represent the views of the DOE or the
U.S. Government. The U.S. Government and the publisher, by
accepting the article for publication, acknowledges that the
U.S. Government retains a nonexclusive, paid-up, irrevocable, world-
wide license to publish or reproduce the published form of this work,
or allow others to do so, for U.S. Government purposes.
AUTHOR CONTRIBUTIONS
Concept, abstract, introduction, editing, and coordination––by R.L.,
A.K., K.F., J.M., T.S., and M.T.; target-specific sections––by authors
provided in the sections' titles.
ORCID
Rosalba Lepore https://orcid.org/0000-0002-9481-2557
Andriy Kryshtafovych https://orcid.org/0000-0001-5066-7178
Krzysztof Fidelis https://orcid.org/0000-0002-8061-412X
Christopher S. Hayes https://orcid.org/0000-0002-2216-6445
Torsten Schwede https://orcid.org/0000-0003-2715-335X
REFERENCES
1. Komander D, Rape M. The ubiquitin code. Annu Rev Biochem. 2012;
81:203-229.
2. Mu JJ, Wang Y, Luo H, et al. A proteomic analysis of ataxia
telangiectasia-mutated (ATM)/ATM-Rad3-related (ATR) substrates
identifies the ubiquitin-proteasome system as a regulator for DNA
damage checkpoints. J Biol Chem. 2007;282(24):17330-17334.
3. Fu X, Yucer N, Liu S, et al. RFWD3-Mdm2 ubiquitin ligase complex
positively regulates p53 stability in response to DNA damage. Proc
Natl Acad Sci U S A. 2010;107(10):4579-4584.
4. Inano S, Sato K, Katsuki Y, et al. RFWD3-mediated ubiquitination pro-
motes timely removal of both RPA and RAD51 from DNA damage
sites to facilitate homologous recombination. Mol Cell. 2017;66(5):
622-634. e628.
5. Lin YC, Wang Y, Hsu R, et al. PCNA-mediated stabilization of E3
ligase RFWD3 at the replication fork is essential for DNA replication.
Proc Natl Acad Sci U S A. 2018;115(52):13282-13287.
6. Knies K, Inano S, Ramirez MJ, et al. Biallelic mutations in the ubiquitin
ligase RFWD3 cause Fanconi anemia. J Clin Invest. 2017;127(8):3013-
3027.
7. Wang Y, Hu XJ, Zou XD, Wu XH, Ye ZQ, Wu YD. WDSPdb: a data-
base for WD40-repeat proteins. Nucleic Acids Res. 2015;43(Database
issue):D339-D344.
8. Feeney L, Munoz IM, Lachaud C, et al. RPA-mediated recruitment of
the E3 ligase RFWD3 is vital for interstrand crosslink repair and
human health. Mol Cell. 2017;66(5):610-621. e614.
9. Uljon S, Xu X, Durzynska I, et al. Structural basis for substrate selec-
tivity of the E3 ligase COP1. Structure. 2016;24(5):687-696.
10. Pinkas DM, Sanvitale CE, Bufton JC, et al. Structural complexity in
the KCTD family of Cullin3-dependent E3 ubiquitin ligases. Biochem
J. 2017;474(22):3747-3761.
11. Brockmann M, Blomen VA, Nieuwenhuis J, et al. Genetic wiring maps
of single-cell protein states reveal an off-switch for GPCR signalling.
Nature. 2017;546(7657):307-311.
12. De Smaele E, Di Marcotullio L, Moretti M, et al. Identification and
characterization of KCASH2 and KCASH3, 2 novel Cullin3 adaptors
suppressing histone deacetylase and hedgehog activity in medullo-
blastoma. Neoplasia. 2011;13(4):374-385.
13. Schwenk J, Perez-Garci E, Schneider A, et al. Modular composition
and dynamics of native GABAB receptors identified by high-
resolution proteomics. Nat Neurosci. 2016;19(2):233-242.
14. Seddik R, Jungblut SP, Silander OK, et al. Opposite effects of KCTD
subunit domains on GABA(B) receptor-mediated desensitization.
J Biol Chem. 2012;287(47):39869-39877.
15. Schwenk J, Metz M, Zolles G, et al. Native GABA(B) receptors are
heteromultimers with a family of auxiliary subunits. Nature. 2010;465
(7295):231-235.
16. Fritzius T, Turecek R, Seddik R, et al. KCTD hetero-oligomers confer
unique kinetic properties on hippocampal GABAB receptor-induced K
+ currents. J Neurosci. 2017;37(5):1162-1175.
17. Jones DT, Cozzetto D. DISOPRED3: precise disordered region predic-
tions with annotated protein-binding activity. Bioinformatics. 2015;31
(6):857-863.
18. Zimmermann L, Stephens A, Nam SZ, et al. A completely
reimplemented MPI bioinformatics toolkit with a new HHpred server
at its core. J Mol Biol. 2018;430(15):2237-2243.
19. Zemla A. LGA: a method for finding 3D similarities in protein struc-
tures. Nucleic Acids Res. 2003;31(13):3370-3374.
20. Hassold T, Hunt P. To err (meiotically) is human: the genesis of human
aneuploidy. Nat Rev Genet. 2001;2(4):280-291.
21. Zickler D, Kleckner N. Recombination, pairing, and synapsis of homo-
logs during meiosis. Cold Spring Harbor Perspect Biol. 2015;7(6):
a016626.
22. Hunter N. Meiotic recombination: the essence of heredity. Cold Spring
Harbor Perspect Biol. 2015;7(12):a016618.
23. Page SL, Hawley RS. Chromosome choreography: the meiotic ballet.
Science. 2003;301(5634):785-789.
24. Meinke P, Schirmer EC. LINC'ing form and function at the nuclear
envelope. FEBS Lett. 2015;589(19 Pt A):2514-2521.
25. Shibuya H, Hernandez-Hernandez A, Morimoto A, Negishi L, Hoog C,
Watanabe Y. MAJIN links telomeric DNA to the nuclear membrane
by exchanging telomere cap. Cell. 2015;163(5):1252-1266.
26. Pendlebury DF, Fujiwara Y, Tesmer VM, et al. Dissecting the
telomere-inner nuclear membrane interface formed in meiosis. Nat
Struct Mol Biol. 2017;24(12):1064-1072.
27. Long J, Huang C, Chen Y, et al. Telomeric TERB1-TRF1 interaction
is crucial for male meiosis. Nat Struct Mol Biol. 2017;24(12):1073-
1080.
28. Shibuya H, Ishiguro K, Watanabe Y. The TRF1-binding protein TERB1
promotes chromosome movement and telomere rigidity in meiosis.
Nat Cell Biol. 2014;16(2):145-156.
LEPORE ET AL. 19
29. Dunce JM, Milburn AE, Gurusaran M, et al. Structural basis of meiotic
telomere attachment to the nuclear envelope by MAJIN-TER-
B2-TERB1. Nat Commun. 2018;9(1):5355.
30. Mir-Sanchis I, Pigli YZ, Rice PA. Crystal structure of an unusual single-
stranded DNA-binding protein encoded by staphylococcal cassette
chromosome elements. Structure. 2018;26(8):1144-1150. e1143.
31. Mir-Sanchis I, Roman CA, Misiura A, Pigli YZ, Boyle-Vavra S, Rice PA.
Staphylococcal SCCmec elements encode an active MCM-like heli-
case and thus may be replicative. Nat Struct Mol Biol. 2016;23(10):
891-898.
32. Jones AM, Low DA, Hayes CS. Can't you hear me knocking: contact-
dependent competition and cooperation in bacteria. Emerging Topics
in Life Sciences. 2017;1(1):75-83.
33. Aoki SK, Pamma R, Hernday AD, Bickham JE, Braaten BA, Low DA.
Contact-dependent inhibition of growth in Escherichia coli. Science.
2005;309(5738):1245-1248.
34. Ruhe ZC, Subramanian P, Song K, et al. Programmed secretion arrest
and receptor-triggered toxin export during antibacterial contact-
dependent growth inhibition. Cell. 2018;175(4):921-933. e914.
35. Willett JL, Ruhe ZC, Goulding CW, Low DA, Hayes CS. Contact-
dependent growth inhibition (CDI) and CdiB/CdiA two-partner secre-
tion proteins. J Mol Biol. 2015;427(23):3754-3765.
36. Garcia EC, Perault AI, Marlatt SA, Cotter PA. Interbacterial signaling
via Burkholderia contact-dependent growth inhibition system pro-
teins. Proc Natl Acad Sci U S A. 2016;113(29):8296-8301.
37. Melvin JA, Gaston JR, Phillips SN, et al. Pseudomonas aeruginosa
contact-dependent growth inhibition plays dual role in host-pathogen
interactions. mSphere. 2017;2(6):e00336.
38. Ghosh A, Baltekin O, Waneskog M, et al. Contact-dependent growth
inhibition induces high levels of antibiotic-tolerant persister cells in
clonal bacterial populations. EMBO J. 2018;37(9):e98026.
39. Morse RP, Nikolakakis KC, Willett JL, et al. Structural basis of toxicity
and immunity in contact-dependent growth inhibition (CDI) systems.
Proc Natl Acad Sci U S A. 2012;109(52):21480-21485.
40. Johnson PM, Beck CM, Morse RP, et al. Unraveling the essential role
of CysK in CDI toxin activation. Proc Natl Acad Sci U S A. 2016;113
(35):9792-9797.
41. Batot G, Michalska K, Ekberg G, et al. The CDI toxin of Yersinia
kristensenii is a novel bacterial member of the RNase a superfamily.
Nucleic Acids Res. 2017;45(9):5013-5025.
42. Michalska K, Gucinski GC, Garza-Sanchez F, et al. Structure of a novel
antibacterial toxin that exploits elongation factor Tu to cleave specific
transfer RNAs. Nucleic Acids Res. 2017;45(17):10306-10320.
43. Michalska K, Quan Nhan D, Willett JLE, et al. Functional plasticity of
antibacterial EndoU toxins. Mol Microbiol. 2018;109(4):509-527.
44. Zhang D, de Souza RF, Anantharaman V, Iyer LM, Aravind L. Polymor-
phic toxin systems: comprehensive characterization of trafficking
modes, processing, mechanisms of action, immunity and ecology
using comparative genomics. Biol Direct. 2012;7:18.
45. Willett JL, Gucinski GC, Fatherree JP, Low DA, Hayes CS. Contact-
dependent growth inhibition toxins exploit multiple independent cell-
entry pathways. Proc Natl Acad Sci U S A. 2015;112(36):11341-
11346.
46. Ghisla S, Thorpe C. Acyl-CoA dehydrogenases. A mechanistic over-
view. Eur J Biochem. 2004;271(3):494-508.
47. Pedersen JI, Veggan T, Bjorkhem I. Substrate stereospecificity in oxi-
dation of (25S)-3 alpha, 7 alpha, 12 alpha-trihydroxy-5 beta-
cholestanoyl-CoA by peroxisomal trihydroxy-5 beta-cholestanoyl-
CoA oxidase. Biochem Biophys Res Commun. 1996;224(1):37-42.
48. Zhang YX, Denoya CD, Skinner DD, et al. Genes encoding acyl-CoA
dehydrogenase (AcdH) homologues from Streptomyces coelicolor
and Streptomyces avermitilis provide insights into the metabolism of
small branched-chain fatty acids and macrolide antibiotic production.
Microbiology. 1999;145(Pt 9):2323-2334.
49. Rohankhedkar MS, Mulrooney SB, Wedemeyer WJ, Hausinger RP.
The AidB component of the Escherichia coli adaptive response to
alkylating agents is a flavin-containing, DNA-binding protein.
J Bacteriol. 2006;188(1):223-230.
50. Ma DK, Li Z, Lu AY, et al. Acyl-CoA dehydrogenase drives heat adap-
tation by sequestering fatty acids. Cell. 2015;161(5):1152-1163.
51. Rotem O, Nesper J, Borovok I, et al. An extended cyclic di-GMP net-
work in the predatory bacterium bdellovibrio bacteriovorus.
J Bacteriol. 2016;198(1):127-137.
52. Hobley L, Fung RK, Lambert C, et al. Discrete cyclic di-GMP-
dependent control of bacterial predation versus axenic growth in
Bdellovibrio bacteriovorus. PLoS Pathog. 2012;8(2):e1002493.
53. Kim JJ, Miura R. Acyl-CoA dehydrogenases and acyl-CoA oxidases.
Structural basis for mechanistic similarities and differences. Eur J Bio-
chem. 2004;271(3):483-493.
54. Chohan KK, Jones M, Grossmann JG, Frerman FE, Scrutton NS,
Sutcliffe MJ. Protein dynamics enhance electronic coupling in elec-
tron transfer complexes. J Biol Chem. 2001;276(36):34142-34147.
55. Toogood HS, van Thiel A, Basran J, Sutcliffe MJ, Scrutton NS, Leys D.
Extensive domain motion and electron transfer in the human electron
transferring flavoprotein medium chain acyl-CoA dehydrogenase
complex. J Biol Chem. 2004;279(31):32904-32912.
56. Landini P, Hajec LI, Volkert MR. Structure and transcriptional regula-
tion of the Escherichia coli adaptive response gene aidB. J Bacteriol.
1994;176(21):6583-6589.
57. Hershey AD, Chase M. Independent functions of viral protein and
nucleic acid in growth of bacteriophage. J Gen Physiol. 1952;36(1):
39-56.
58. Benzer S. Fine structure of a genetic region in bacteriophage. Proc
Natl Acad Sci U S A. 1955;41(6):344-354.
59. Barrangou R, Fremaux C, Deveau H, et al. CRISPR provides acquired
resistance against viruses in prokaryotes. Science. 2007;315(5819):
1709-1712.
60. Deveau H, Garneau JE, Moineau S. CRISPR/Cas system and its role in
phage-bacteria interactions. Annu Rev Microbiol. 2010;64:475-493.
61. Haq IU, Chaudhry WN, Akhtar MN, Andleeb S, Qadri I. Bacterio-
phages and their implications on future biotechnology: a review. Virol
J. 2012;9:9.
62. Schmelcher M, Loessner MJ. Application of bacteriophages for detec-
tion of foodborne pathogens. Bacteriophage. 2014;4(1):e28137.
63. Furfaro LL, Payne MS, Chang BJ. Bacteriophage therapy: clinical trials
and regulatory hurdles. Front Cell Infect Microbiol. 2018;8:376.
64. Bartual SG, Otero JM, Garcia-Doval C, et al. Structure of the bacterio-
phage T4 long tail fiber receptor-binding tip. Proc Natl Acad Sci U S A.
2010;107(47):20287-20292.
65. Leiman PG, Arisaka F, van Raaij MJ, et al. Morphogenesis of the T4
tail and tail fibers. Virol J. 2010;7:355.
66. Hu B, Margolin W, Molineux IJ, Liu J. Structural remodeling of bacte-
riophage T4 and host membranes during infection initiation. Proc Natl
Acad Sci U S A. 2015;112(35):E4919-E4928.
67. Taylor NM, Prokhorov NS, Guerrero-Ferreira RC, et al. Structure of
the T4 baseplate and its function in triggering sheath contraction.
Nature. 2016;533(7603):346-352.
68. Dunne M, Denyes JM, Arndt H, Loessner MJ, Leiman PG, Klumpp J.
Salmonella phage S16 tail fiber adhesin features a rare polyglycine rich
domain for host recognition. Structure. 2018;26(12):1573-1582. e1574.
69. Denyes JM, Dunne M, Steiner S, et al. Modified bacteriophage S16
long tail fiber proteins for rapid and specific immobilization and
detection of salmonella cells. Appl Environ Microbiol. 2017;83(12):
e00277.
70. Trojet SN, Caumont-Sarcos A, Perrody E, Comeau AM, Krisch HM.
The gp38 adhesins of the T4 superfamily: a complex modular deter-
minant of the phage's host specificity. Genome Biol Evol. 2011;3:
674-686.
20 LEPORE ET AL.
71. Riede I, Drexler K, Schwarz H, Henning U. T-even-type bacterio-
phages use an adhesin for recognition of cellular receptors. J Mol Biol.
1987;194(1):23-30.
72. Warkentin E, Weidenweber S, Schuhle K, Demmer U, Heider J,
Ermler U. A rare polyglycine type II-like helix motif in naturally occur-
ring proteins. Proteins. 2017;85(11):2017-2023.
73. Richards TA, Dacks JB, Campbell SA, et al. Evolutionary origins of the
eukaryotic shikimate pathway: gene fusions, horizontal gene transfer,
and endosymbiotic replacements. Eukaryot Cell. 2006;5(9):1517-
1531.
74. Bentley R. The shikimate pathway--a metabolic tree with many bra-
nches. Crit Rev Biochem Mol Biol. 1990;25(5):307-384.
75. Duke SO, Powles SB. Glyphosate: a once-in-a-century herbicide. Pest
Manag Sci. 2008;64(4):319-325.
76. Carpenter EP, Hawkins AR, Frost JW, Brown KA. Structure of
dehydroquinate synthase reveals an active site capable of multistep
catalysis. Nature. 1998;394(6690):299-302.
77. Gourley DG, Shrive AK, Polikarpov I, et al. The two types of
3-dehydroquinase have distinct structures but catalyze the same
overall reaction. Nat Struct Biol. 1999;6(6):521-525.
78. Gan J, Wu Y, Prabakaran P, et al. Structural and biochemical analyses
of shikimate dehydrogenase AroE from Aquifex aeolicus: implications
for the catalytic mechanism. Biochemistry. 2007;46(33):9513-9522.
79. Hartmann MD, Bourenkov GP, Oberschall A, Strizhov N,
Bartunik HD. Mechanism of phosphoryl transfer catalyzed by
shikimate kinase from Mycobacterium tuberculosis. J Mol Biol. 2006;
364(3):411-423.
80. Schonbrunn E, Eschenburg S, Shuttleworth WA, et al. Interaction of the
herbicide glyphosate with its target enzyme 5-enolpyruvylshikimate
3-phosphate synthase in atomic detail. Proc Natl Acad Sci U S A. 2001;
98(4):1376-1380.
81. Fuchs ACD, Alva V, Maldoner L, Albrecht R, Hartmann MD, Martin J.
The architecture of the anbu complex reflects an evolutionary inter-
mediate at the origin of the proteasome system. Structure. 2017;25
(6):834-845. e835.
82. Leiman PG, Basler M, Ramagopal UA, et al. Type VI secretion appara-
tus and phage tail-associated protein complexes share a common
evolutionary origin. Proc Natl Acad Sci U S A. 2009;106(11):4154-
4159.
83. Brackmann M, Nazarov S, Wang J, Basler M. Using force to punch
holes: mechanics of contractile nanomachines. Trends Cell Biol. 2017;
27(9):623-632.
84. Nguyen VS, Douzi B, Durand E, Roussel A, Cascales E, Cambillau C.
Towards a complete structural deciphering of type VI secretion sys-
tem. Curr Opin Struct Biol. 2018;49:77-84.
85. Hurst MR, Glare TR, Jackson TA. Cloning Serratia entomophila anti-
feeding genes--a putative defective prophage active against the grass
grub Costelytra zealandica. J Bacteriol. 2004;186(15):5116-5128.
86. Taylor NMI, van Raaij MJ, Leiman PG. Contractile injection systems of
bacteriophages and related systems.Mol Microbiol. 2018;108(1):6-15.
87. Ge P, Scholl D, Leiman PG, Yu X, Miller JF, Zhou ZH. Atomic struc-
tures of a bactericidal contractile nanotube in its pre- and postco-
ntraction states. Nat Struct Mol Biol. 2015;22(5):377-382.
88. Mougous JD, Cuff ME, Raunser S, et al. A virulence locus of Pseudo-
monas aeruginosa encodes a protein secretion apparatus. Science.
2006;312(5779):1526-1530.
89. Kanamaru S, Leiman PG, Kostyuchenko VA, et al. Structure of the
cell-puncturing device of bacteriophage T4. Nature. 2002;415(6871):
553-557.
90. Scott-Craig JS, Borrusch MS, Banerjee G, Harvey CM, Walton JD.
Biochemical and molecular characterization of secreted alpha-
xylosidase from Aspergillus Niger. J Biol Chem. 2011;286(50):42848-
42854.
91. Jabbour D, Borrusch MS, Banerjee G, Walton JD. Enhancement of
fermentable sugar yields by alpha-xylosidase supplementation of
commercial cellulases. Biotechnol Biofuels. 2013;6(1):58.
92. Himmel ME, Ding SY, Johnson DK, et al. Biomass recalcitrance: engi-
neering plants and enzymes for biofuels production. Science. 2007;
315(5813):804-807.
93. Larsbrink J, Izumi A, Hemsworth GR, Davies GJ, Brumer H. Structural
enzymology of Cellvibrio japonicus Agd31B protein reveals alpha-
transglucosylase activity in glycoside hydrolase family 31. J Biol Chem.
2012;287(52):43288-43299.
94. Lombard V, Golaconda Ramulu H, Drula E, Coutinho PM, Henrissat B.
The carbohydrate-active enzymes database (CAZy) in 2013. Nucleic
Acids Res. 2014;42(Database issue):D490-D495.
95. McCarter JD, Withers SG. Mechanisms of enzymatic glycoside hydro-
lysis. Curr Opin Struct Biol. 1994;4(6):885-892.
96. Bliven S, Lafita A, Parker A, Capitani G, Duarte JM. Automated evalu-
ation of quaternary structures from protein crystals. PLoS Comput
Biol. 2018;14(4):e1006104.
97. Janson CA, Kayne PS, Almassy RJ, Grunstein M, Eisenberg D.
Sequence of glutamine synthetase from salmonella typhimurium and
implications for the protein structure. Gene. 1986;46(2–3):297-300.
98. Dodson G, Wlodawer A. Catalytic triads and their relatives. Trends
Biochem Sci. 1998;23(9):347-352.
SUPPORTING INFORMATION
Additional supporting information may be found online in the
Supporting Information section at the end of this article.
How to cite this article: Lepore R, Kryshtafovych A,
Alahuhta M, et al. Target highlights in CASP13: Experimental
target structures through the eyes of their authors. Proteins.
2019;1–21. https://doi.org/10.1002/prot.25805
LEPORE ET AL. 21
